search
Back to results

Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy (Empower)

Primary Purpose

Breast Cancer, Upper Extremity Dysfunction

Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
general exercise
Sponsored by
University of Alberta
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Breast Cancer focused on measuring exercise, physical therapy, eHealth

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleDoes not accept healthy volunteers

Inclusion Criteria:

  • adult females with a diagnosis of breast cancer (Stage Ic-III);
  • be able to participate in mild levels of activity at minimum;
  • have completed cancer surgery involving a mastectomy or breast conserving surgery involving either an axillary lymph node dissection or sentinel lymph node biopsy;
  • starting adjuvant chemotherapy +/- biological therapy treatment (eligible from 4 weeks post-operatively up to the point of the start of the second cycle of chemotherapy);
  • speak and understand English.

Exclusion Criteria:

  • unable to commit to the 10-week virtual program including testing sessions at the Cancer Rehabilitation clinic in the Corbett Hall at the University of Alberta;
  • do not have regular access to the internet and a smart device or computer in the home.
  • have undergone, or are scheduled to undergo, neoadjuvant chemotherapy

Sites / Locations

  • University of Alberta/ Cross Cancer InstituteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Standard exercise program

Integrated physiotherapy and exercise

Arm Description

Participants in this group will take part the general exercise program delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application.

Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules.

Outcomes

Primary Outcome Measures

Completion rate
Defined as >70% participants completing at least 70% of exercise sessions and the post-study assessment

Secondary Outcome Measures

Recruitment rate
Percentage of participants eligible who consent to participate in the study
Attendance rate
Percentage of completed exercise and education modules
Program Satisfaction
Program Satisfaction Questionnaire
Symptoms
Edmonton Symptom Assessment System
Health-related Quality of Life
Functional Assessment of Cancer Therapy -breast (FACT-B+4)
Fatigue
Functional Assessment of Cancer Therapy - fatigue subscale (FACIT-F)
Physical Activity
Godin Leisure Time Exercise Questionnaire
Cost-effectiveness
EuroQol 5-Dimension 5-Level (EQ-5D-5L)
Walking endurance
Six-minute walk test
Lower body strength
Thirty second sit-to-stand
Flexibility Shoulder Flexion
Active Shoulder Range of Motion: flexion
Flexibility Shoulder Abduction
Active Shoulder Range of Motion: abduction
Flexibility Shoulder External Rotation
Active Shoulder Range of Motion: external rotation
Flexibility Shoulder Internal Rotation
Active Shoulder Range of Motion: internal rotation
Flexibility Shoulder Horizontal Abduction
Active Shoulder Range of Motion: horizontal abduction
Flexibility lower body
Sit-and-reach
Balance
One-leg Stance Test
Arm volume
Perometry for the measurement of lymphedema
Body weight
Measurement of weight in kgs
Body height
Measurement of height in cms

Full Information

First Posted
February 14, 2022
Last Updated
October 21, 2023
Sponsor
University of Alberta
search

1. Study Identification

Unique Protocol Identification Number
NCT05254678
Brief Title
Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy
Acronym
Empower
Official Title
Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy (EMPOWER): A Randomized Controlled Feasibility Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 20, 2023 (Actual)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of Alberta

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The primary purpose of this study is to determine the feasibility of our proposed intervention approach involving (1) an integrated physiotherapy and exercise intervention for individuals with breast cancer who are undergoing chemotherapy and (2) delivery of programming via an electronic health (eHealth) application. The secondary objective is to determine the efficacy of the program on upper extremity outcomes, general physical fitness, cancer treatment-related symptoms and quality of life.
Detailed Description
EMPOWER is a multi-methods feasibility randomized controlled trial. The study will recruit a minimum of 30 individuals with breast cancer who are undergoing adjuvant chemotherapy following surgery for breast cancer. The study will be conducted in two phases: Phase I: Randomized Controlled Feasibility Trial The aim of this phase is to determine the feasibility and preliminary efficacy of a 10-week integrated physiotherapy and exercise intervention compared to an exercise intervention alone. Phase II: Qualitative Study The aim of this phase is to evaluate the acceptability of the Healthy Eating, Active Living and Mindful Energy (HEAL-ME) Research App design, program delivery, program components and perceived effectiveness of the intervention at the level of the participant. PHASE I: Randomized Controlled Feasibility Trial A randomized controlled trial design will be used to randomize individuals with breast cancer to one of two groups: 1) Comparison group: general exercise intervention + education; and 2) Experimental group: integrated physiotherapy and general exercise intervention + education. The study will be carried out over a 10-week period. The outcome measures will be assessed at baseline and at 10 weeks. Randomization: An independent researcher will generate the randomization sequence using a computer-generated randomization module within the Trial's REDCap database. Randomization will occur following baseline testing. Interventions: Group 1 (Comparator): Hybrid In-Persona and HEAL-ME delivered General Exercise: Participants in this group will take part the general exercise program delivered in-person and through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions in-person or virtually (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application. Exercise regimen: The exercise regimen follows the general principles of overload, progression, and specificity. The exercise program consists of full body exercise (e.g., comprising aerobic, resistance training, core stability, balance and flexibility training) a minimum of 2 times per week (one group virtual session and one independent self-directed session). Education: educational materials in written (PDF format) will be included in the Education module: resources section of the HEAL-ME application. Topics include the exercise expectations, behavior change strategies, home exercise equipment and how to exercise safely. Group 2 (Experimental): Hybrid in-person and HEAL-ME Integrated Physiotherapy and exercise: Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered in-person and through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions in-person or virtually, (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules. Integrated physiotherapy and exercise regimen: The integrated physiotherapy and exercise regimen will follow the exercise regimen as described in Group 1. For this group, breast cancer specific shoulder range of motion and stretching exercises will be incorporated into the warm-up and cool-down components of both group and individual exercise sessions. Education: educational videos will be available on the application and include topics such as cancer-related fatigue, risk reduction for lymphedema and pelvic health after breast cancer. Educational materials in written (PDF format) will be included in the Education module: resources section of the HEAL-ME application. Topics include the benefits of exercise during chemotherapy for breast cancer, exercise behavior change strategies, and how to exercise safely. Blinding An independent assessor, who is blinded to the group assignment will carry out all the measurements. Training of the assessor will be conducted on the measurement procedures related to the upper body and fitness outcome measurement protocols prior to study initiation. PHASE II: Assessment of HEAL-ME App Design, Acceptability, and Program Components The app design, acceptability, and program components will be assessed following completion of the study through focus groups and semi-structured interviews to explore the experiences of individuals randomized to the HEAL-ME experimental group. The purpose of this phase is to assess different aspects of HEAL-ME related to the program delivery, different components contents, and time commitment. The results of this phase will inform further development of the HEAL- ME breast cancer module. Phase II Data Collection Focus Groups: E-intervention group participants will be invited to participate in a focus group or semi-structured interview session that aim to capture participant perspectives and experiences, as well as any facilitators or barriers to use of the HEAL-ME application. Qualitative Data Analysis The focus groups discussions will be audio recorded and transcribed. Two researchers will read and then reread the transcripts for accuracy against the audio recordings. The investigators will conduct an inductive content analysis to capture the participants' views about the program's acceptability and usability and ways to refine it. The inductive approach will enable a descriptive evaluation of the program from the participant's view. Two researchers will independently analyze the content of the focus group transcripts to identify evidence related to research objectives. Using the thematic analytic approach, the investigators will follow different processes described by Braun and Clarke. The data will be analyzed line by line by the researchers independently to identify patterns and key themes with example quotes from the data. Codes for similar meanings and highlighted terms will be developed, examined, and refined if necessary to identify the most expressive codes related to the research objectives. The process will be repeated a few times until concrete themes emerge and no further themes are identified. The generated themes will be reviewed and verified by a third researcher in order to increase the validity of the findings. Any coding discrepancies will be discussed and reconciled. Conceptual themes will be inductively originated from analysis through generating initial codes, followed by sub-themes, and finally, an overarching theme.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Breast Cancer, Upper Extremity Dysfunction
Keywords
exercise, physical therapy, eHealth

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled feasibility trial
Masking
Outcomes Assessor
Masking Description
Independent assessors will be used for collection of objective outcomes. The independent assessors will be blinded to group allocation.
Allocation
Randomized
Enrollment
30 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standard exercise program
Arm Type
Active Comparator
Arm Description
Participants in this group will take part the general exercise program delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent exercise workouts within the application, and (3) exercise specific education within the Education Module of the HEAL-ME application.
Arm Title
Integrated physiotherapy and exercise
Arm Type
Experimental
Arm Description
Participants in this group will take part in an integrated physiotherapy and exercise intervention delivered through the Active Living module of the HEAL-ME application. The program comprises (1) supervised group physiotherapeutic exercise sessions (connection via zoom platform embedded in HEAL-ME), (2) independent physiotherapeutic exercise workouts, and (3) breast cancer specific physiotherapy education delivered through weekly modules.
Intervention Type
Behavioral
Intervention Name(s)
general exercise
Other Intervention Name(s)
physiotherapy
Intervention Description
A 10-week integrated physiotherapy and general exercise intervention compared to a general exercise intervention alone.
Primary Outcome Measure Information:
Title
Completion rate
Description
Defined as >70% participants completing at least 70% of exercise sessions and the post-study assessment
Time Frame
10 weeks
Secondary Outcome Measure Information:
Title
Recruitment rate
Description
Percentage of participants eligible who consent to participate in the study
Time Frame
one year
Title
Attendance rate
Description
Percentage of completed exercise and education modules
Time Frame
10 weeks
Title
Program Satisfaction
Description
Program Satisfaction Questionnaire
Time Frame
10 weeks
Title
Symptoms
Description
Edmonton Symptom Assessment System
Time Frame
10 weeks
Title
Health-related Quality of Life
Description
Functional Assessment of Cancer Therapy -breast (FACT-B+4)
Time Frame
10 weeks
Title
Fatigue
Description
Functional Assessment of Cancer Therapy - fatigue subscale (FACIT-F)
Time Frame
10 weeks
Title
Physical Activity
Description
Godin Leisure Time Exercise Questionnaire
Time Frame
10 weeks
Title
Cost-effectiveness
Description
EuroQol 5-Dimension 5-Level (EQ-5D-5L)
Time Frame
10 weeks
Title
Walking endurance
Description
Six-minute walk test
Time Frame
10 weeks
Title
Lower body strength
Description
Thirty second sit-to-stand
Time Frame
10 weeks
Title
Flexibility Shoulder Flexion
Description
Active Shoulder Range of Motion: flexion
Time Frame
10 weeks
Title
Flexibility Shoulder Abduction
Description
Active Shoulder Range of Motion: abduction
Time Frame
10 weeks
Title
Flexibility Shoulder External Rotation
Description
Active Shoulder Range of Motion: external rotation
Time Frame
10 weeks
Title
Flexibility Shoulder Internal Rotation
Description
Active Shoulder Range of Motion: internal rotation
Time Frame
10 weeks
Title
Flexibility Shoulder Horizontal Abduction
Description
Active Shoulder Range of Motion: horizontal abduction
Time Frame
10 weeks
Title
Flexibility lower body
Description
Sit-and-reach
Time Frame
10 weeks
Title
Balance
Description
One-leg Stance Test
Time Frame
10 weeks
Title
Arm volume
Description
Perometry for the measurement of lymphedema
Time Frame
10 weeks
Title
Body weight
Description
Measurement of weight in kgs
Time Frame
10 weeks
Title
Body height
Description
Measurement of height in cms
Time Frame
10 weeks
Other Pre-specified Outcome Measures:
Title
Grip strength (optional)
Description
Dynamometry
Time Frame
10 weeks
Title
Core muscular endurance (optional)
Description
Plank endurance test
Time Frame
10 weeks

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: adult females with a diagnosis of breast cancer (Stage Ic-III); be able to participate in mild levels of activity at minimum; have completed cancer surgery involving a mastectomy or breast conserving surgery involving either an axillary lymph node dissection or sentinel lymph node biopsy; having completed or undergoing adjuvant chemotherapy +/- biological therapy treatment (eligible from 4 weeks to one year post-surgery at baseline); speak and understand English. Exclusion Criteria: unable to commit to the 10-week virtual program including testing sessions at the Cancer Rehabilitation clinic in the Corbett Hall at the University of Alberta; do not have regular access to the internet and a smart device or computer in the home. are scheduled to undergo neoadjuvant chemotherapy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Margaret L McNeely
Phone
1-780-492-6007
Email
mmcneely@ualberta.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margaret McNeely
Organizational Affiliation
University of Alberta
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Alberta/ Cross Cancer Institute
City
Edmonton
State/Province
Alberta
ZIP/Postal Code
T6G 2G4
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Margaret McNeely, PhD
Phone
780-248-1531
Email
mmcneely@ualberta.ca
First Name & Middle Initial & Last Name & Degree
Margaret L. McNeely, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
On completion of the trial, data will be available through the University of Alberta's Dataserve
IPD Sharing Time Frame
On completion of the trial.
IPD Sharing Access Criteria
The data on repository will be available on request to the principal investigator.

Learn more about this trial

Exercise Rehabilitation Via a Mobile Application for Individuals With Breast Cancer Undergoing Chemotherapy

We'll reach out to this number within 24 hrs